Published in Schizophr Res on September 04, 2014
Increased Levels of C1q in the Prefrontal Cortex of Adult Offspring after Maternal Immune Activation: Prevention by 7,8-Dihydroxyflavone. Clin Psychopharmacol Neurosci (2017) 0.79
Gastroenterology issues in schizophrenia: why the gut matters. Curr Psychiatry Rep (2015) 0.78
Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder. NPJ Schizophr (2016) 0.78
Cerebral complement C1q activation in chronic Toxoplasma infection. Brain Behav Immun (2016) 0.77
Errant gardeners: glial-cell-dependent synaptic pruning and neurodevelopmental disorders. Nat Rev Neurosci (2017) 0.75
The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis. Mol Psychiatry (2017) 0.75
Complement. First of two parts. N Engl J Med (2001) 11.16
The classical complement cascade mediates CNS synapse elimination. Cell (2007) 9.06
Complement. Second of two parts. N Engl J Med (2001) 6.32
Functional requirement for class I MHC in CNS development and plasticity. Science (2000) 5.57
Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry (2010) 5.27
Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci (2002) 4.36
Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry (2004) 3.52
Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort. Am J Psychiatry (2014) 2.91
Immune proteins in brain development and synaptic plasticity. Neuron (2009) 2.72
Placental transport of immunoglobulin G. Vaccine (2003) 2.62
Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry (2004) 2.23
MHC class I: an unexpected role in neuronal plasticity. Neuron (2009) 2.20
Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry (2012) 1.91
Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol (1996) 1.79
Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring. Am J Psychiatry (2012) 1.72
Toxoplasma infection and later development of schizophrenia in mothers. Am J Psychiatry (2011) 1.69
Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun (2008) 1.67
TGF-β signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat Neurosci (2013) 1.56
Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry (2007) 1.54
Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Transl Psychiatry (2013) 1.46
Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J Neurosci (2011) 1.41
The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biol Psychiatry (2011) 1.36
Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophr Bull (2000) 1.35
A dramatic increase of C1q protein in the CNS during normal aging. J Neurosci (2013) 1.35
A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. Schizophr Bull (2000) 1.26
Developmental neuroinflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.26
Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol Psychiatry (2013) 1.16
A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr Res (2010) 1.14
Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia. Biol Psychiatry (2008) 1.10
Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. Microbes Infect (2009) 1.09
Nonaffective psychosis after prenatal exposure to rubella. Am J Psychiatry (2000) 1.09
Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder. Mol Psychiatry (2013) 1.07
Effects of maternal immune activation on gene expression patterns in the fetal brain. Transl Psychiatry (2012) 1.05
The complement system in schizophrenia. Drug News Perspect (2008) 1.02
Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res (2012) 1.01
Cognitive functioning prior to the onset of psychosis: the role of fetal exposure to serologically determined influenza infection. Biol Psychiatry (2009) 1.00
C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J Invest Dermatol (2005) 1.00
Synapse remodeling, compliments of the complement system. Cell (2007) 0.96
The neurodevelopmental hypothesis of schizophrenia: convergent clues from epidemiology and neuropathology. Psychiatr Clin North Am (2012) 0.93
Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia. Neurobiol Dis (2012) 0.92
MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease. J Neurosci (2013) 0.91
Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia. Schizophr Res (2010) 0.89
Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring--a matched case-control study. Schizophr Res (2012) 0.89
Anti-gluten immune response following Toxoplasma gondii infection in mice. PLoS One (2012) 0.86
The complement system at the embryo implantation site: friend or foe? Front Immunol (2012) 0.84
Cryoglobulins as indicators of upregulated immune response in schizophrenia. Clin Biochem (2007) 0.84
Association of C1QB gene polymorphism with schizophrenia in Armenian population. BMC Med Genet (2011) 0.84
Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia. BMC Clin Pathol (2011) 0.84
[Concentration and protein composition of circulating immune complexes in the blood of patients with schizophrenia and subjects with positive familial history of disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2005) 0.81
[Circulating immune complexes in the serum of mental patients and healthy subjects]. Zh Nevropatol Psikhiatr Im S S Korsakova (1984) 0.78